PIA
APLT

Perennial Investment Advisors’s Applied Therapeutics APLT Stock Holding History

Perennial Investment Advisors’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,600
Closed -$1.16K – 516
2025
Q4 		$1.16K Hold
11,600
– – ﹤0.01% 511
2025
Q3 		$7.02K Hold
11,600
– – ﹤0.01% 482
2025
Q2 		$3.61K Hold
11,600
– – ﹤0.01% 475
2025
Q1 		$5.67K Hold
11,600
– – ﹤0.01% 433
2024
Q4 		$9.93K Hold
11,600
– – ﹤0.01% 405
2024
Q3 		$98.6K Hold
11,600
– – 0.01% 389
2024
Q2 		$54.2K Hold
11,600
– – 0.01% 363
2024
Q1 		$78.9K Hold
11,600
– – 0.01% 349
2023
Q4 		$38.9K Hold
11,600
– – 0.01% 336
2023
Q3 		$28.9K Hold
11,600
– – 0.01% 349
2023
Q2 		$14.8K Hold
11,600
– – ﹤0.01% 355
2023
Q1 		$9.41K Hold
11,600
– – ﹤0.01% 366
2022
Q4 		$8.82K Hold
11,600
– – ﹤0.01% 219
2022
Q3 		$11K Buy
+11,600
New +$13.9K 0.01% 201

Perennial Investment Advisors's APLT Position: Q1 2026 in Review

Perennial Investment Advisors sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 11,600 shares — an estimated $1.16K sold.

Perennial Investment Advisors first reported a position in APLT in Q3 2022 and held it in 14 quarters. The position peaked at $98.6K in Q3 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

  • Perennial Investment Advisors reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Perennial Investment Advisors sold 11,600 Applied Therapeutics shares in Q1 2026, an estimated $1.16K.
  • Perennial Investment Advisors first reported a position in Applied Therapeutics in Q3 2022 and held it in 14 quarters.
  • Perennial Investment Advisors's Applied Therapeutics position peaked at $98.6K in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on Perennial Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.